EarlySight Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $11.4M

  • Investors
  • 12

EarlySight General Information

Description

Developer of a medical device designed to help doctors detect and treat eye diseases. The company's device uses cellular-level imaging technology that detects minor structural changes of the retina, and transscleral illumination allows the monitoring of day-to-day effects of treatment in a non-invasive manner, enabling eye specialists to visualize the morphology of numerous cells in the retina.

Contact Information

Website
www.earlysight.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenue de Sécheron 15
  • 1202 Geneva
  • Switzerland
+41 078
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Avenue de Sécheron 15
  • 1202 Geneva
  • Switzerland
+41 078

EarlySight Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EarlySight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 08-Sep-2025 $11.4M Completed Generating Revenue
10. Equity Crowdfunding 03-May-2025 Completed Generating Revenue
9. Accelerator/Incubator 20-May-2024 Completed Generating Revenue
8. Accelerator/Incubator 31-Oct-2023 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Seed Round 06-May-2021 Completed Generating Revenue
5. Seed Round 01-Aug-2020 Completed Generating Revenue
4. Grant 10-Mar-2020 Completed Startup
3. Accelerator/Incubator 06-Feb-2020 Completed Startup
2. Accelerator/Incubator 19-Jul-2019 Completed Startup
To view EarlySight’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

EarlySight Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

EarlySight Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4327723-A1 Retina tissue image acquisition Inactive 26-Aug-2022
EP-4577097-A1 Retina tissue image acquisition Pending 26-Aug-2022
WO-2024042230-A1 Retina tissue image acquisition Inactive 26-Aug-2022
EP-4518742-A1 Method and use of transscleral optical imaging for detecting a disease Pending 30-Apr-2022
US-20250299325-A1 Method and use of transscleral optical imaging for detecting a disease Pending 30-Apr-2022 G06T7/0012
To view EarlySight’s complete patent history, request access »

EarlySight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EarlySight Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cadfem Germany Corporation Minority
Fongit Accelerator/Incubator Minority
Zürcher Kantonalbank Asset Manager Minority
EPFL Innovation Park Accelerator/Incubator
Nova Capital (Italy) Growth/Expansion Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

EarlySight FAQs

  • When was EarlySight founded?

    EarlySight was founded in 2019.

  • Where is EarlySight headquartered?

    EarlySight is headquartered in Geneva, Switzerland.

  • What is the size of EarlySight?

    EarlySight has 9 total employees.

  • What industry is EarlySight in?

    EarlySight’s primary industry is Diagnostic Equipment.

  • Is EarlySight a private or public company?

    EarlySight is a Private company.

  • What is the current valuation of EarlySight?

    The current valuation of EarlySight is .

  • What is EarlySight’s current revenue?

    The current revenue for EarlySight is .

  • How much funding has EarlySight raised over time?

    EarlySight has raised $14.8M.

  • Who are EarlySight’s investors?

    Cadfem Germany, Fongit, Zürcher Kantonalbank, EPFL Innovation Park, and Nova Capital (Italy) are 5 of 12 investors who have invested in EarlySight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process